StressMarq Biosciences is a research reagents company manufacturing antibodies, proteins, ELISA kits, and small molecules. It is currently the only company worldwide that manufactures active recombinant alpha synuclein and tau fibrillar “seeds” that can generate Lewy body and tau pathologies, respectively. These have become increasingly popular in generating neurodegenerative disease models. Additionally, StressMarq has pursued patent protection for an antibody with alpha synuclein aggregation neutralization capability, resulting in a therapeutic candidate for Parkinson’s and Alzheimer’s.
SOLA is a biotherapeutics company focusing on developing transformative therapies to treat protein misfolding diseases. SOLA’s technology is designed to harness the power of a patient’s own chaperones to repair disease-causing proteins. Our innovative engineered chaperone technology enables the repairing of misfolded proteins which cause devastating neurogenerative diseases such as Huntington and Parkinson’s diseases.